Seller record · trimrx.com

TrimRx

Recorded September 2026 · Standard v1.1

Fails 2 of 8 criteria. S3, pharmacy identification: The footer names a legal category rather than a pharmacy, and no pharmacy name appears on the homepage, treatment, FAQ, contact, about, safety, shipping, terms or privacy pages. 1 more criterion also fails; see the table below.

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A California telehealth platform connecting buyers with third-party clinician networks for GLP-1 treatment. It states that it is neither a medical practice nor a pharmacy, and it names no filling pharmacy on any page read.

Operating entity Metafit Pharma Solutions, Inc.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	trimrx.com/terms-and-conditions
S2	Prescription gating	PASS	start.trimrx.com/intake/trimrx/glp1/name
S3	Pharmacy identification	FAIL	trimrx.com
S4	Compounding disclosure	PASS	trimrx.com
S5	Analytical documentation	FAIL	trimrx.com/safety-information
S6	Business address	PASS	trimrx.com/contact-us
S7	Price disclosure	PASS	trimrx.com/terms-and-conditions
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSThe terms state that an affiliated healthcare provider decides medical appropriateness and issues any prescription; no individual clinician is named.Source: trimrx.com/terms-and-conditions.

S2PASSThe order path was walked and stopped at the third intake screen, which demanded identity data before any product selection or payment.Source: start.trimrx.com/intake/trimrx/glp1/name.

S3FAILThe footer names a legal category rather than a pharmacy, and no pharmacy name appears on the homepage, treatment, FAQ, contact, about, safety, shipping, terms or privacy pages.Source: trimrx.com.

S4PASSThe footer carries the words compounded and not FDA-approved in visible text, and the safety information page repeats the disclosure.Source: trimrx.com.

S5FAILNo certificate of analysis, chromatogram or lot document is linked on any page read, and the safety page instead states that quality varies between compounding pharmacies.Source: trimrx.com/safety-information.

S6PASSThe contact page prints a street address with a suite number under a heading reading Our Offices, repeated in the terms mailing block.Source: trimrx.com/contact-us.

S7PASSThe terms price the initial GLP-1 package at 199 dollars for the first month and 299 dollars thereafter, while the homepage tile prints starting at 179 dollars with no term attached.Source: trimrx.com/terms-and-conditions.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide programs, compounded tirzepatide programs, prescriptions for branded Ozempic and Zepbound.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.